Azacitidine Combined With Venetoclax in Patients With Higher-risk Chronic Myelomonocytic Leukemia (AVENHIR)
Clinical trial NCT05768711 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05768711
- Sponsor
- Groupe Francophone des Myelodysplasies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-04
- Primary completion
- 2026-05-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.